AI Assistant
Blog
Pricing
Log In
Sign Up
CMET-45. CHECKPOINT BLOCKADE IMMUNOTHERAPIES FOR MELANOMA BRAIN METASTASES: IMPROVED SURVIVAL OUTCOMES IN A NATIONAL COHORT
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
